Stock Evaluator: Anteris Technologies Global Corp. (AVR)

Anteris Technologies Global Corp. AVR

$5.32 -0.38 -6.67%
November 17, 2026 4:00:00 PM EST November 10, 2021 Volume: 1,179,331
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.

Commentary & Analysis


Financial Summary

Share Statistics AVR Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $555.7 $380.3 39%
Shares Out (Mil) 97.5 41.2 61%
Institutional Ownership 98.9% 84.0% 83%
Float (Mil) 68.8 35.2 53%
Beta na 0.85 na
Avg Daily Volume (000s) 1,142 341 70%
Price Change
(52-week)
50.4% 59.6% 87%
Growth AVR Industry
Median
Percentile
(All Stocks)
Sales (5yr) (19.2%) 11.8% 3%
Net Income (5yr) (51.5%) (5.6%) 7%
EPS (5yr) (5.1%) 10.6% 25
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (15.0%) (16.0%) 52%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 4 4 5
Current EPS ($0.221) ($1.071) ($1.159)
Month Ago EPS ($0.308) ($1.181) ($1.154)
# Rev Up 1 0 0
# Rev Down 0 1 1
Three Months Ago EPS ($0.290) ($1.190) ($0.885)
Year/Year Chg (19.6%) (58.0%) (60.8%)
Financials AVR Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $2 $127 3%
Net Income (TTM) (Mil) ($108) ($9) 10%
EPS (TTM) ($1.363) ($0.300) 18%
Operating Cash Flow (TTM) (Mil) ($91) ($1) 7%
Net Cash Flow (TTM) (Mil) $227 $2 85%
Long-Term Debt (Q1) (Mil) $16 $25 31%
Enterprise Value (Q1) (Mil) $389 $400 32%
Valuation AVR Industry
Median
Percentile
(All Stocks)
P/B 2.45 2.62 63%
P/E na 26.0 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.3 na
Ratios AVR Industry
Median
Percentile
(All Stocks)
Gross Margin 75.8% 59.1% 86%
Net Margin na (4.5%) na
ROA (76.8%) (11.0%) 7%
ROE (93.8%) (8.5%) 9%
Liabilities to Assets 13.5% 45.9% 8%
F-Score 4 4 33%

Anteris Technologies Global Corp. did not pass any screens on 11/16/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors